Insider Trading - Nussbaum Ran

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Nussbaum Ran

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-05-09
Purchase
2017-05-11
2:02 pm
Kite Pharma Inc. KITE Nussbaum Ran
Director
9,832 $69.11 $679,474 2,632
(Indirect
Direct)
View
2018-03-21
Purchase
2018-03-23
4:20 pm
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
12,600 $7.7643 $97,830 427,063
(Indirect)
View
2018-04-30
Purchase
2018-05-01
4:34 pm
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
350,000 $9.75 $3,412,500 520,396
(Indirect)
View
2018-05-18
Purchase
2018-05-18
5:41 pm
ARQULE INC ARQL Nussbaum Ran
Director
8,611 $3.29 $28,330 8,611
(Direct)
View
2018-05-18
Purchase(A)
2018-05-22
09:22 am
ARQULE INC ARQL Nussbaum Ran
Director
8,611 $3.29 $28,330 8,611
(Indirect)
View
2018-07-13
Purchase
2018-10-22
2:54 pm
ARQULE INC ARQL Nussbaum Ran
Director
181,818 $5.5 $999,999 1,630,657
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:51 pm
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
200,000 $9 $1,800,000 24,000
(Indirect)
View
2019-06-27
Purchase
2019-07-01
11:50 am
ARQULE INC ARQL Nussbaum Ran
Director
307,692 $9.75 $2,999,997 36,923
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:16 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2021-05-13
Purchase
2021-05-17
07:02 am
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
5,925,925 $1.35 $7,999,999 616,592
(Indirect)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-06-20
Option Award
2017-06-22
2:37 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
2,410 $0 4,360
(Direct)
View
2017-06-20
Option Award
2017-06-22
2:37 pm
N/A
2027-06-19
Kite Pharma Inc. KITE Nussbaum Ran
Director
8,810 $0 8,810
(Direct)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
4,360 $0 0
(Direct)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
3,520 $0 0
(Indirect)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
2,651 $0 0
(Indirect)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
1,029 $0 0
(Indirect)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
N/A
Kite Pharma Inc. KITE Nussbaum Ran
Director
2,632 $0 0
(Indirect)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
2024-03-24
Kite Pharma Inc. KITE Nussbaum Ran
Director
50,000 $178.65 0
(Direct)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
2025-06-08
Kite Pharma Inc. KITE Nussbaum Ran
Director
10,000 $120.77 0
(Direct)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
2026-05-31
Kite Pharma Inc. KITE Nussbaum Ran
Director
7,000 $129.13 0
(Direct)
View
2017-10-03
Disposition
2017-10-05
8:26 pm
N/A
2027-06-19
Kite Pharma Inc. KITE Nussbaum Ran
Director
8,810 $88.79 0
(Direct)
View
2017-11-08
Option Award
2017-11-09
12:14 pm
N/A
2027-11-08
ARQULE INC ARQL Nussbaum Ran
Director
30,000 $0 30,000
(Direct)
View
2018-05-08
Option Award
2018-05-10
12:45 pm
N/A
2028-05-08
ARQULE INC ARQL Nussbaum Ran
Director
20,000 $0 20,000
(Direct)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
1,762,000 $0 1,762,000
(Indirect)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
3,259,000 $0 3,259,000
(Indirect)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
1,587,000 $0 1,587,000
(Indirect)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
476,000 $0 476,000
(Indirect)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
880,000 $0 880,000
(Indirect)
View
2018-05-08
Other
2018-05-25
4:30 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
428,000 $0 428,000
(Indirect)
View
2018-06-15
Option Award
2018-06-19
6:17 pm
N/A
2028-06-15
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
40,000 $0 40,000
(Direct)
View
2019-05-14
Option Award
2019-05-15
12:44 pm
N/A
2029-05-13
ARQULE INC ARQL Nussbaum Ran
Director
40,000 $0 40,000
(Direct)
View
2019-05-29
Option Award
2019-05-29
5:21 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
20,000 $0 20,000
(Direct)
View
2019-05-29
Option Award
2019-05-30
3:45 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
20,000 $0 20,000
(Direct)
View
2019-06-03
Option Award
2019-06-05
4:55 pm
N/A
2029-06-02
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
10,000 $0 10,000
(Direct)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
30,476 $1.75 1,913,166
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
56,368 $1.75 3,538,592
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
27,442 $1.75 1,723,115
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
2021-10-20
ARQULE INC ARQL Nussbaum Ran
Director
30,476 $0 445,524
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
2021-10-20
ARQULE INC ARQL Nussbaum Ran
Director
56,368 $0 823,632
(Indirect)
View
2019-09-12
Exercise
2019-09-16
4:42 pm
N/A
2021-10-20
ARQULE INC ARQL Nussbaum Ran
Director
27,442 $0 400,558
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
445,524 $1.75 2,358,690
(Indirect)
View
2019-12-24
Tax Withholding
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
38,770 $20.11 2,319,920
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
823,632 $1.75 4,362,224
(Indirect)
View
2019-12-24
Tax Withholding
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
71,674 $20.11 4,290,550
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
400,558 $1.75 2,123,673
(Indirect)
View
2019-12-24
Tax Withholding
2019-12-27
8:48 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
34,857 $20.11 2,088,816
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
445,524 $0 0
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
823,632 $0 0
(Indirect)
View
2019-12-24
Exercise
2019-12-27
8:48 pm
N/A
2022-05-08
ARQULE INC ARQL Nussbaum Ran
Director
400,558 $0 0
(Indirect)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
2,319,920 $20 0
(Indirect)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
4,290,550 $20 0
(Indirect)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
2,088,816 $20 0
(Indirect)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
36,923 $20 0
(Indirect)
View
2020-01-16
Equity Swap
2020-01-16
3:57 pm
N/A
N/A
ARQULE INC ARQL Nussbaum Ran
Director
8,611 $20 0
(Indirect)
View
2020-01-16
Disposition
2020-01-16
3:57 pm
N/A
2027-11-08
ARQULE INC ARQL Nussbaum Ran
Director
30,000 $0 0
(Direct)
View
2020-01-16
Disposition
2020-01-16
3:57 pm
N/A
2028-05-08
ARQULE INC ARQL Nussbaum Ran
Director
20,000 $0 0
(Direct)
View
2020-01-16
Disposition
2020-01-16
3:57 pm
N/A
2029-05-13
ARQULE INC ARQL Nussbaum Ran
Director
40,000 $0 0
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 1,734,395
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 844,371
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 937,735
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 1,903,702
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 926,796
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 1,029,273
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 68,654
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 2,067,314
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 1,015,256
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 1,108,926
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 105,512
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 0
(Indirect)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
20,000 $0 20,000
(Direct)
View
2020-06-08
Option Award
2020-06-10
6:41 pm
N/A
2030-06-07
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
10,000 $0 10,000
(Direct)
View
2020-06-17
Option Award
2020-06-19
6:38 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Nussbaum Ran
Director
17,000 $0 17,000
(Direct)
View
2021-01-22
Equity Swap
2021-01-26
5:07 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Nussbaum Ran
Director
1,576,881 $0 0
(Indirect)
View
2021-01-22
Disposition
2021-01-26
5:07 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Nussbaum Ran
Director
17,000 $0 0
(Direct)
View
2021-03-24
Exercise
2021-04-22
5:18 pm
N/A
N/A
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
1,030 $5 1,465,199
(Indirect)
View
2021-03-24
Exercise
2021-04-22
5:18 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
1,030 $0 0
(Indirect)
View
2021-05-19
Option Award
2021-05-20
4:10 pm
N/A
2031-05-19
Eloxx Pharmaceuticals Inc. ELOX Nussbaum Ran
Director
20,000 $0 20,000
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:34 pm
N/A
2031-05-31
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
8,293 $0 8,293
(Direct)
View
2021-03-25
Exercise
2021-06-09
1:42 pm
N/A
N/A
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
2,211 $5 1,433,928
(Indirect)
View
2021-03-25
Exercise
2021-06-09
1:42 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
2,211 $0 0
(Indirect)
View
2021-03-25
Option Award
2021-06-09
1:42 pm
N/A
2031-06-06
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
6,817 $0 6,817
(Indirect)
View
2021-03-25
Option Award
2021-06-09
1:42 pm
N/A
2031-06-06
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
3,183 $0 3,183
(Indirect)
View
2021-03-25
Exercise
2021-06-09
1:46 pm
N/A
N/A
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
1,030 $5 1,431,717
(Indirect)
View
2021-03-25
Exercise
2021-06-09
1:46 pm
2014-07-27
2021-07-27
UroGen Pharma Ltd. URGN Nussbaum Ran
Director
1,030 $0 0
(Indirect)
View